High-dose bevacizumab improved survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 15 de mayo del 2005

Translation for this article does not exist

Blogs

Smoothies for All Occasions
by OncoLink Editorial Team
May 24, 2016